Quercetin Efficiently Alleviates TNF-α-Stimulated Injury by Signal Transducer and Activator of Transcription 1 and Mitogen-Activated Protein Kinase Pathway in H9c2 Cells: A Protective Role of Quercetin in Myocarditis
Overview
Affiliations
This study aimed to evaluate the protective effect of quercetin and its in-depth mechanism in TNF-α-stimulated cardiomyocytes. The differential expression of TNF-alpha (TNF-α) and signal transducer and activator of transcription 1 (STAT1) was analyzed based on the GEO database. H9c2 cells were stimulated with TNF-α to simulate myocarditis. Cell counting kit-8 assay and flow cytometry assay were performed to detect the cell viability and apoptosis. ELISA was used to measure the levels of proinflammatory cytokines (IL-6 and IL-17A) and anti-inflammatory cytokine (IL-10). STAT1 expression was downregulated by transfection with si-STAT1, and its expression was detected using quantitative real-time polymerase chain reaction and Western blot. Western blot was also performed to assess the expression of the mitogen-activated protein kinase (MAPK) pathway-related factors. In this article, TNF-α was highly expressed in patients with myocarditis, and TNF-α (20 μg/mL) declined the viability of H9c2 cells. Quercetin pretreatment partially alleviated the decrease of cell viability, the increase of apoptosis, and the release of inflammatory cytokines (IL-10, IL-6, and IL-17A) induced by TNF-α. In addition, TNF-α increased STAT1 expression, but quercetin prevented the TNF-α-increased STAT1 level. Remarkably, knockdown of STAT1 enhanced the protective effect of quercetin on TNF-α-injured H9c2 cells. Moreover, quercetin restrained the TNF-α-induced activation of the MAPK pathway. Also, the inhibitory effect of quercetin on the pathway was aggravated by STAT1 lacking. In summing, quercetin plays a protective role in TNF-α-stimulated H9c2 cell injury, which may be related to the regulation of STAT1 and MAPK pathway.
Wu X, Liu A, Lv X, Zhi X, Zeng X, Liu K Heliyon. 2024; 10(20):e38851.
PMID: 39640819 PMC: 11620105. DOI: 10.1016/j.heliyon.2024.e38851.
MicroRNAs in Myocarditis-Review of the Preclinical In Vivo Trials.
Procyk G, Grodzka O, Procyk M, Gasecka A, Gluszek K, Wrzosek M Biomedicines. 2023; 11(10).
PMID: 37893097 PMC: 10604573. DOI: 10.3390/biomedicines11102723.
Zhang D, Hong L, Zhang R, Zhang Q, Yao J, Wang J Medicine (Baltimore). 2023; 102(34):e34615.
PMID: 37653797 PMC: 10470687. DOI: 10.1097/MD.0000000000034615.
Yao T, Sun B, Li Y, Sun Y, Zhang G, Yue G Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(9):2151-2163.
PMID: 36961551 DOI: 10.1007/s00210-023-02464-y.
Zhou P, Ma Y, Zhao X, Hua F Inflammopharmacology. 2023; 31(1):207-220.
PMID: 36609715 DOI: 10.1007/s10787-022-01130-8.